Landfar Bio-medicine Co., Ltd (SHE:000504)

Landfar Bio-medicine Revenue

Landfar Bio-medicine had revenue of 120.33M CNY in the quarter ending September 30, 2026, with 277.83% growth. This brings the company's total for the last twelve months to 748.74M, up 496.75% year-over-year. In the year 2025, Landfar Bio-medicine had annual revenue of 415.94M with 209.37% growth. That makes Landfar Bio-medicine the 21,779th largest company in the world by revenue and 3,991st in China.

• Revenue (ttm): 748.74M
• Revenue Growth: +496.75%
• P/S Ratio: 3.64
• Revenue / Employee: 2.37M
• Employees: 316
• Market Cap: 2.73B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Scrap Steel Recycling, Processing and Sales 206.05M 49.5%
• Lithium Carbonate Production and Sales 81.52M 19.6%
• Human Cell Detection and Storage 72.67M 17.5%
• Sales of Biopharmaceutical Related Products 39.18M 9.4%
• Energy Saving and Environmental Protection Services 15.15M 3.6%
• Undistributed 1.37M 0.3%

Fiscal year ended Dec 31, 2025 See the full Landfar Bio-medicine breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	415.94M	281.49M	209.37%
Dec 31, 2024	134.45M	-2.34M	-1.71%
Dec 31, 2023	136.79M	-63.55M	-31.72%
Dec 31, 2022	200.35M	43.73M	27.92%
Jan 1, 2022	156.62M	-18.95M	-10.79%

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 3, 2026

Data Sources Report a data error